INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$34K
1,882 sh
Jan 22, 2026Jan 26, 2026
Page 414 of 550
← PrevNext →
traded Jan 22, 2026
+4d
SEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$142K
1,100 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

6
CF
Cheng Chi FungDirector, Chief Technology Officer
CRDOCredo Technology Group Holding Ltd
Open-market sale · 10b5-1 plan
SELL$43K
300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$66K
5,230 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

5
SN
Sagati Aghili NaseemGeneral Counsel
ARESAres Management Corp
Open-market sale · 10b5-1 plan
SELL$33K
200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$686K
45.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$676K
45.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

4
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$230K
1,798 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$676K
45.0K sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

70
NR
Nielson Brandon R.Director
NANAKeystone Private Income Fund
Open-market purchase
BUY$2.00M
20.3K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

63
EJ
Earl JohnPresident
NANAKeystone Private Income Fund
Open-market purchase
BUY$1000K
10.1K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

61
AJ
Agarwal A.J.Director, Co-President
NONENONEBlackstone Real Estate Income Trust, Inc.
Open-market purchase
BUY$4.00M
287.3K sh
Dec 1, 2025Jan 23, 2026
traded Dec 1, 2025
+53dSEC Form 4

Evidence

58
AB
Allen BradTreasurer
NANAKeystone Private Income Fund
Open-market purchase
BUY$1.00M
10.1K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

46
KR
Kushel J. RichardSenior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$22.50M
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

45
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Open-market sale
SELL$863K
8,798 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

45
CM
Carr James McgregorExecutive Vice Pres.
CMACOMERICA INC
Open-market sale
SELL$981K
10.0K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$8.12M
87.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4.93M
52.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
10.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

42
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$86K
926 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

40
WG
Woodruff Ronald GreerEVP Safety, ESG, Maintenance
JBHTHUNT J B TRANSPORT SERVICES INC
Open-market sale
SELL$288K
1,391 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

38
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$170K
1,822 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

38
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$222K
2,382 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

36
HW
Hicks Bradley W.President of DCS
JBHTHUNT J B TRANSPORT SERVICES INC
Open-market sale
SELL$824K
3,919 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.39M
26.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.54M
27.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
GV
Gadde VijayaDirector
PLPlanet Labs PBC
Open-market sale
SELL$535K
20.0K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.02M
23.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.75M
19.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.99M
33.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

35
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
500 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

34
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Open-market sale
SELL$5.93M
492.8K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

32
KL
Klobnak Jennifer LCHIEF OPERATING OFFICER
RLIRLI CORP
Open-market purchase
BUY$116K
2,000 sh
Jan 23, 2026Jan 23, 2026
traded Jan 23, 2026
+0dSEC Form 4

Evidence

27
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Open-market sale
SELL$879K
73.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

26
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.96M
66.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

26
SA
Schreiber Daniel A.Director, Chief Executive Officer
LMNDLemonade, Inc.
Open-market sale · 10b5-1 plan
SELL$12.00M
126.6K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

26
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Open-market sale · 10b5-1 plan
SELL$599K
12.8K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

22
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$2.59M
65.8K sh
Jan 20, 2026Jan 23, 2026
traded Jan 20, 2026
+3dSEC Form 4

Evidence